王盼盼，女，汉族，1985年出生，博士，中共党员。2010年毕业于洛阳师范学院化学化工学院化学工程与工艺专业，获学士学位；2013年毕业于郑州大学化工与能源学院制药工程专业，获工学硕士学位；2017年毕业于重庆大学药学院化学工程与技术专业，获工学博士学位，师从朱峰教授。

主要从事制药工程方面的教学科研工作。主讲本科生《药物分析技术》、《药品生产质量管理规范》。研究方向：计算机辅助药物设计。参与完成国家自然科学青年基金项目1项；参与完成中组部“青年千人计划”项目1项；主持完成重庆市研究生科创新项目1项。发表SCI收录论文5篇(一作3篇，共同一作2篇)。

代表学术成果：

1、Panpan Wang, Xiaoyu Zhang, Tingting Fu, Shuang Li, Bo Li, Weiwei Xue*, Xiaojun Yao, Yuzong Chen, Feng Zhu*. Differentiating physicochemical properties between addictive and non-addictive ADHD drugs revealed by molecular dynamics simulation studies. ACS Chem. Neuros. 2017, 8(6): 1416-1428.

2、Panpan Wang, Tingting Fu, Xiaoyu Zhang, Fengyuan Yang, Guoxun Zheng, Weiwei Xue*, Yuzong Chen, Xiaojun Yao, Feng Zhu*. Differentiating physicochemical properties between NDRIs and sNRIs clinically important for the treatment of ADHD. BBA Gen. Subj. [Epub ahead of print] doi:10.1016/j.bbagen.2017.07.022 (2017).

3、Yinghong Li#, Panpan Wang#, Xiaoxu Li#, Chunyan Yu, Hong Yang, Jin Zhou, Weiwei Xue, Jun Tan, Feng Zhu*. The human kinome targeted by FDA approved multi-target drugs and combination products: a comparative study from the drug-target interaction network perspective. PLoS ONE. 2016, 11(11): e0165737.

4、Jingyu Xu#, Panpan Wang#, Hong Yang#, Jin Zhou, Yinghong Li, Xiaoxu Li, Weiwei Xue, Chunyan Yu, Feng Zhu*. Comparison of FDA approved kinase targets to clinical trial ones: insights from their system profiles and drug-target interaction networks. Biom. Res. Intern. 2016, 2016: 2509385.

5、Panpan Wang, Fengyuan Yang, Hong Yang, Xiaofei Xu, Duo Liu, Weiwei Xue, Feng Zhu*. Identification of dual active agents targeting 5-HT1A and SERT by combinatorial virtual screening methods. Bio-Medical Mater. and Engin. 2015, 26 Suppl 1: S2233-2239.